EW vs JBGS · P/E 47, rev $3.39B vs rev $257.0M
Edwards Lifesciences Corp (EW) versus JBG SMITH Properties (JBGS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
JBG SMITH Properties (JBGS) is a reit - office company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported JBGS revenue for 2026-06-30 was $257.0M. Net income was -$77.9M. JBGS currently screens at market cap $1.31B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. JBGS currently screens at market cap $1.31B.
Not investment advice. Open the EW and JBGS stock pages for the full models.
Not investment advice.